Endocrine Abstracts (2017) 50 P418 | DOI: 10.1530/endoabs.50.P418

Thyroid related adverse effects of Alemtuzumab in patients with multiple sclerosis- Experience from a single tertiary level centre

Aprajita Pradhan1, Freya Edwards1 & WC Candy Sze1,2


1Queen Mary University, London, UK; 2The Royal London Hospital, London, UK


Abstract withdrawn.

Article tools

My recent searches

No recent searches.